Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: EGO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on EGO, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,678,313 EGO shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,678,313 shares
    Change vs previous 13F +626,171 shares

    0.96% of the 13F portfolio, value $52,178,993.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,052,142 shares
    Change vs previous 13F -613,228 shares

    0.7% of the 13F portfolio, value $36,118,923.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,665,370 shares
    Change vs previous 13F -608,149 shares

    1.26% of the 13F portfolio, value $59,824,576.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,273,519 shares
    Change vs previous 13F -693,921 shares

    1.47% of the 13F portfolio, value $65,686,919.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,967,440 shares
    Change vs previous 13F -835,455 shares

    1.87% of the 13F portfolio, value $60,362,335.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,802,895 shares
    Change vs previous 13F +1,152,909 shares

    2% of the 13F portfolio, value $63,969,826.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,649,986 shares
    Change vs previous 13F +2,296,018 shares

    1.37% of the 13F portfolio, value $39,408,474.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 353,968 shares
    Change vs previous 13F not available

    0.21% of the 13F portfolio, value $6,148,867.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).